| A Study to Compare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive, and Shared Epitope-positive Rheumatoid Arthritis and an Inadequate Response to Methotrexate | 2021-09-15 | 2023-06-14 | |
| A Study of Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That May Have Invaded The Muscle Wall of the Bladder and Who Cannot Get Cisplatin, A Type of Medicine Given To Treat Bladder Cancer | 2020-02-05 | 2023-06-07 | |
| A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer | 2017-12-19 | 2023-06-01 | |
| A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer | 2020-02-06 | 2023-06-01 | |
| A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165 in Participants With Moderate to Severe Ulcerative Colitis | 2021-03-15 | 2023-05-31 | |
| Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Participants With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer | 2019-11-20 | 2023-01-16 | 2024-01-12 |
| A Study to Assess BMS-986207 in Combination With Nivolumab and Ipilimumab as First-line Treatment for Participants With Stage IV Non-Small Cell Lung Cancer | 2022-10-03 | 2022-12-27 | 2023-12-15 |
| An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease | 2018-07-16 | 2022-12-12 | |
| Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis | 2020-01-07 | 2022-12-05 | 2023-12-05 |
| A Study to Evaluate BMS-986141 Added on to Aspirin or Ticagrelor or the Combination, on Thrombus Formation in a Thrombosis Chamber Model in Participants With Stable Coronary Artery Disease and Healthy Participants | 2022-03-25 | 2022-11-14 | 2023-11-13 |
| A Study of Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 With or Without Bacillus Calumette-Guerin (BCG) in BCG Unresponsive Bladder Cancer That Has Not Invaded Into the Muscle Wall of the Bladder | 2018-08-02 | 2022-08-22 | 2023-05-03 |
| A Study of BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic Dermatitis | 2021-08-17 | 2022-08-22 | 2023-08-21 |
| A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis | 2020-07-29 | 2022-08-04 | |
| Effectiveness Study of Nivolumab Compared to Placebo in Prevention of Recurrent Melanoma After Complete Resection of Stage IIB/C Melanoma | 2019-10-28 | 2022-06-28 | 2023-06-26 |
| Continuing Treatment for Subjects Who Have Participated on a Prior Protocol Investigating Dasatinib | 2015-07-31 | 2022-05-15 | 2023-04-13 |
| An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers | 2016-10-05 | 2022-05-13 | 2023-05-03 |
| A Study to Test Combination Treatments in Participants With Advanced Gastric Cancer | 2016-11-29 | 2022-05-11 | 2023-05-09 |
| A Study of Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H) | 2018-10-31 | 2022-05-03 | 2023-04-24 |
| A Study of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650) | 2017-03-26 | 2022-04-05 | 2023-03-30 |
| A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel | 2019-01-27 | 2022-03-31 | 2023-03-31 |
| An Investigational Immuno-therapy Study of Nivolumab, Pomalidomide and Dexamethasone Combinations in Patients With Multiple Myeloma | 2016-08-10 | 2022-03-09 | 2023-02-28 |
| An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma | 2019-10-31 | 2022-02-27 | |
| An Exploratory Study of the Effects of Nivolumab Combined With Ipilimumab in Patients With Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC) | 2017-03-29 | 2022-02-17 | 2023-02-02 |
| A Study to Evaluate Mavacamten in Adults With Symptomatic Obstructive HCM Who Are Eligible for Septal Reduction Therapy | 2020-07-06 | 2022-02-07 | 2023-02-07 |
| A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Who Failed 1L or 2L EGFR Tyrosine Kinase Inhibitor (TKI) Therapy | 2017-03-17 | 2022-01-20 | 2023-01-10 |
| A Study to Test Combination Treatments in People With Advanced Renal Cell Carcinoma | 2017-02-02 | 2021-11-23 | 2022-11-18 |
| A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma | 2018-09-21 | 2021-11-19 | 2022-11-18 |
| A Study of Combination Nivolumab and Ipilimumab Retreatment in Patients With Advanced Renal Cell Carcinoma | 2020-09-03 | 2021-11-15 | 2022-11-15 |
| A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation | 2017-01-19 | 2021-10-18 | 2022-04-07 |
| A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen | 2014-04-09 | 2021-10-06 | 2022-09-29 |
| A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC) | 2017-03-04 | 2021-09-08 | 2022-08-31 |
| Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise | 2020-10-14 | 2021-08-12 | 2022-08-10 |
| A Study of Neoadjuvant Nivolumab + Palbociclib + Anastrozole in Post-Menopausal Women and Men With Primary Breast Cancer | 2019-10-18 | 2021-07-27 | 2022-07-14 |
| A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase | 2015-10-22 | 2021-07-07 | 2022-01-07 |
| An Investigational Study to Evaluate BMS-986165 in Participants With Systemic Lupus Erythematosus | 2017-09-21 | 2021-06-29 | 2022-06-29 |
| Safety and Efficacy of Deucravacitinib in Participants With Moderate to Severe Ulcerative Colitis | 2019-07-01 | 2021-06-13 | 2022-06-09 |
| Study of Nivolumab in Combination With Ipilimumab Compared to the Standard of Care (Extreme Regimen) as First Line Treatment in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | 2016-10-05 | 2021-05-10 | 2022-04-06 |
| An Immuno-Therapy Study of Experimental Medication BMS-986205 Given With Nivolumab With or Without Chemotherapy Compared to Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer | 2018-05-24 | 2021-04-25 | |
| An Investigational Study to Evaluate Experimental Medication BMS-986165 in Japanese Participants With Moderate-to-Severe Psoriasis | 2019-04-10 | 2021-03-24 | 2022-10-06 |
| A Study of Nivolumab Plus Brentuximab Vedotin Versus Brentuximab Vedotin Alone in Patients With Advanced Stage Classical Hodgkin Lymphoma, Who Are Relapsed/ Refractory or Who Are Not Eligible for Autologous Stem Cell Transplant, | 2017-06-26 | 2021-02-22 | 2022-02-11 |
| Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer | 2017-06-02 | 2021-02-16 | 2022-02-15 |
| An Investigational Immunotherapy Study of Nivolumab With Standard of Care Therapy vs Standard of Care Therapy for First-Line Treatment of Colorectal Cancer That Has Spread | 2018-02-20 | 2021-02-01 | 2022-02-01 |
| A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma | 2018-04-11 | 2021-01-25 | 2022-01-25 |
| A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin | 2017-06-29 | 2021-01-18 | 2022-01-11 |
| An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or Enzalutamide in Metastatic Castration-resistant Prostate Cancer | 2017-12-19 | 2021-01-13 | 2022-01-13 |
| An Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer) | 2016-05-09 | 2020-12-22 | 2021-11-30 |
| An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis | 2018-07-26 | 2020-11-29 | 2022-10-06 |
| An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis | 2019-07-15 | 2020-10-29 | 2022-09-16 |
| A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis | 2018-06-12 | 2020-10-08 | 2022-08-22 |
| A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis | 2018-06-19 | 2020-09-14 | 2022-08-16 |